Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study (Q80178463)
Jump to navigation
Jump to search
scientific article published on 01 April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study |
scientific article published on 01 April 2007 |
Statements
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study (English)
Susan R Rheingold
Michael D Hogarty
Susan M Blaney
James A Zwiebel
Calies Sauk-Schubert
Reddy Chandula
Mark D Krailo
Peter C Adamson
Children's Oncology Group Study
1 April 2007